ScreenerHero

PBF Planet Based Foods Global Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · planetbasedfoods.com
0.0150CAD0.00%Mkt Cap: 399654 $P/E: —

Planet Based Foods Global Inc., through its subsidiaries, develops, manufactures, and sells vegan meat-analog-based products derived from hemp plant proteins under the H.E.M.P. brand. It offers its products for the whole…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap399.65K USD
Enterprise Value768.99K USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)542.92K USD
Revenue/Share—
Last Price0.0150 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA72703G2027
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.42
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.00504% of range0.2700
52W High0.2700 CAD
52W Low0.0050 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.08%
ROA5859.47%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-227.80K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-106.47%
Net Debt386.82K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.25
Current Ratio0.01
Quick Ratio0.01
Book Value/Sh-0.04 CAD
Cash/Share0.00 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateNov 23, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.34.99M
Float14.61M
Insiders72.98%
Institutions0.00%
Short Interest
Short Ratio0.7d
Short % Out.0.00%
Shares Short649
Short (prev mo.)1.72K
Technical
SMA 500.0171 (-12.3%)
SMA 2000.0282 (-46.8%)
Beta0.04
S&P 52W Chg16.45%
Avg Vol (30d)967
Avg Vol (10d)0
Technical Indicators
RSI (14)38.7
MACD-0.0009
MACD Signal-0.0010
MACD Hist.+0.0001
BB Upper0.0194 CAD
BB Middle0.0158 CAD
BB Lower0.0121 CAD
BB Width46.52%
ATR (14)0.0004 CAD
Vol Ratio (20d)0.00x